Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapoxetine for Premature Ejaculation in Men with Erectile Dysfunction
NCT01063855Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Apr 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of dapoxetine in premature ejaculation (PE), sponsored by Johnson & Johnson. Started Apr 2010; status: completed.
02
Drugs
dapoxetine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT01063855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01063855.